{"title":"托珠单抗治疗SARS-Cov-2疫苗接种后的严重甲状腺功能障碍视神经病变:头两例报告病例","authors":"Habibullah Eatamadi","doi":"10.52768/2379-1039/2051","DOIUrl":null,"url":null,"abstract":"Background: Thyroid eye disease is a condition that is mostly associated with Graves disease. It is an autoimmune condition that can have various clinical presentations and associations. Recently association of COVID-19 infection and/or vaccination with de novo occurrence of thyroid eye disease has been described.","PeriodicalId":294824,"journal":{"name":"Open Journal of Clinical and Medical Case Reports","volume":"66 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Severe dysthyroid optic neuropathy following SARS-Cov-2 vaccination treated with tocilizumab: First two reported cases\",\"authors\":\"Habibullah Eatamadi\",\"doi\":\"10.52768/2379-1039/2051\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Thyroid eye disease is a condition that is mostly associated with Graves disease. It is an autoimmune condition that can have various clinical presentations and associations. Recently association of COVID-19 infection and/or vaccination with de novo occurrence of thyroid eye disease has been described.\",\"PeriodicalId\":294824,\"journal\":{\"name\":\"Open Journal of Clinical and Medical Case Reports\",\"volume\":\"66 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Journal of Clinical and Medical Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52768/2379-1039/2051\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Journal of Clinical and Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52768/2379-1039/2051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Severe dysthyroid optic neuropathy following SARS-Cov-2 vaccination treated with tocilizumab: First two reported cases
Background: Thyroid eye disease is a condition that is mostly associated with Graves disease. It is an autoimmune condition that can have various clinical presentations and associations. Recently association of COVID-19 infection and/or vaccination with de novo occurrence of thyroid eye disease has been described.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
